Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 28 symbols : SNY save search
United States Human Vaccines Markets, 2018-2021 & Forecast to 2028: Approval/launches of the New Vaccines / Rising Focus on Immunization Programs / Increasing Investments and Government Support
Published: 2022-06-28 (Crawled : 21:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
DVAX | $11.35 -0.7% -0.7% 2.2M
|
Health Technology
|
| O: 0.08%
H: 5.75%
C: 5.01%
vaccine
Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D., to its Board of Directors
Published: 2022-06-28 (Crawled : 21:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
RLAY | $6.12 -1.45% -1.47% 2.9M
|
Health Technology
|
| O: -1.62%
H: 5.43%
C: 4.25%
CLLS | $2.48 0.81% 0.4% 15K
|
Health Technology
|
| O: -3.78%
H: 3.57%
C: 2.5%
Survey: Digital Workplaces Help Frontline Teams Look Beyond the "Big Quit"
Published: 2022-06-28 (Crawled : 15:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
Hepion Pharmaceuticals Further Strengthens Board with Appointments of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati
Published: 2022-06-28 (Crawled : 13:00) - contravir.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
HEPA | $2.1 -1.41% -1.43% 28K
|
Health Technology
|
| O: -0.36%
H: 1.49%
C: -2.99%
G1 Therapeutics Announces Addition of Jacks Lee to Board of Directors
Published: 2022-06-28 (Crawled : 12:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
GTHX | $4.16 -2.8% -2.88% 690K
|
Health Technology
|
| O: 0.0%
H: 3.18%
C: -3.18%
therapeutics
Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease
Published: 2022-06-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
nexviadyme treatment care disease approved potential
Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD
Published: 2022-06-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
xenpozyme treatment approved
Sanofi Enters into a Partnering Agreement with Health2Sync
Published: 2022-06-28 (Crawled : 04:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
agreement sanofi
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.06%
H: 1.27%
C: -0.44%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
pharma
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.